Beijing Chunlizhengda Medical Instruments Co Ltd
SSE:688236
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (35), the stock would be worth ¥24.98 (44% upside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 24.3 | ¥17.3 |
0%
|
| 3-Year Average | 35 | ¥24.98 |
+44%
|
| 5-Year Average | 33 | ¥23.5 |
+36%
|
| Industry Average | 33.5 | ¥23.9 |
+38%
|
| Country Average | 29.6 | ¥21.13 |
+22%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
¥7.4B
|
/ |
Jan 2026
¥272.5m
|
= |
|
|
¥7.4B
|
/ |
Dec 2026
¥350m
|
= |
|
|
¥7.4B
|
/ |
Dec 2027
¥431.3m
|
= |
|
|
¥7.4B
|
/ |
Dec 2028
¥507.5m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CN |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SSE:688236
|
6.6B CNY | 24.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
162.5B USD | 57.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
157.7B USD | 24.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 35.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
103.9B USD | 22.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
85.4B USD | 23.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 44.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.3B EUR | 18.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.7B USD | 42.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.4B USD | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
31.1B USD | 19.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 17.1 |
| Median | 29.6 |
| 70th Percentile | 57.7 |
| Max | 43 569.3 |
Other Multiples
Beijing Chunlizhengda Medical Instruments Co Ltd
Glance View
Beijing Chunlizhengda Medical Instruments Co Ltd is a CN-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Beijing, Beijing and currently employs 951 full-time employees. The company went IPO on 2021-12-30. Beijing Chunlizhengda Medical Instruments Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of implantable orthopedic medical devices. The firm's main products are joint prosthesis products and spine implant products. The joint prosthesis products cover four human joints: hip, knee, shoulder and elbow. The spine implant products are a full range of product combinations of spinal internal fixation systems. The firm's products are exported to Asia, South America, Africa, Oceania, Europe and other countries and regions.
